Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01805 is a long intergenic non-protein coding RNA gene, meaning its transcript is a long RNA molecule (typically over 200 nucleotides) that does not code for a protein and is situated between protein-coding genes in the genome. LincRNAs as a class are known to participate in gene expression regulation, chromatin remodeling, and transcriptional control—often with tissue specificity and sometimes affecting processes such as cell differentiation or genome architecture. However, no specific functional characterization, disease association, or clinical relevance has yet been directly attributed to LINC01805. There are currently no known drugs or clinical interventions that target this RNA, and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1805 (LINC01805).